» Articles » PMID: 21504412

Dysbindin-containing Complexes and Their Proposed Functions in Brain: from Zero to (too) Many in a Decade

Overview
Journal ASN Neuro
Specialties Chemistry
Neurology
Date 2011 Apr 21
PMID 21504412
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Dysbindin (also known as dysbindin-1 or dystrobrevin-binding protein 1) was identified 10 years ago as a ubiquitously expressed protein of unknown function. In the following years, the protein and its encoding gene, DTNBP1, have become the focus of intensive research owing to genetic and histopathological evidence suggesting a potential role in the pathogenesis of schizophrenia. In this review, we discuss published results demonstrating that dysbindin function is required for normal physiology of the mammalian central nervous system. In tissues other than brain and in non-neuronal cell types, the protein has been characterized as a stable component of a multi-subunit complex, named BLOC-1 (biogenesis of lysosome-related organelles complex-1), which has been implicated in intracellular protein trafficking and the biogenesis of specialized organelles of the endosomal-lysosomal system. In the brain, however, dysbindin has been proposed to associate into multiple complexes with alternative binding partners, and to play a surprisingly wide variety of functions including transcriptional regulation, neurite and dendritic spine formation, synaptic vesicle biogenesis and exocytosis, and trafficking of glutamate and dopamine receptors. This puzzling array of molecular and functional properties ascribed to the dysbindin protein from brain underscores the need of further research aimed at ascertaining its biological significance in health and disease.

Citing Articles

Association of DBNDD1 with prognostic and immune biomarkers in invasive breast cancer.

Huang X, Wang Y, Wang J, Jing Y, Dilraba E, Li Y Discov Oncol. 2025; 16(1):218.

PMID: 39979699 PMC: 11842647. DOI: 10.1007/s12672-025-01990-w.


Impact of cannabinoids on synapse markers in an SH-SY5Y cell culture model.

Jahn K, Blumer N, Wieltsch C, Duzzi L, Fuchs H, Meister R Schizophrenia (Heidelb). 2024; 10(1):96.

PMID: 39448630 PMC: 11502758. DOI: 10.1038/s41537-024-00498-6.


Decoding the nexus: branched-chain amino acids and their connection with sleep, circadian rhythms, and cardiometabolic health.

Li H, Seugnet L Neural Regen Res. 2024; 20(5):1350-1363.

PMID: 39075896 PMC: 11624887. DOI: 10.4103/NRR.NRR-D-23-02020.


Emergence of Extracellular Vesicles as "Liquid Biopsy" for Neurological Disorders: Boom or Bust.

Kumar A, Nader M, Deep G Pharmacol Rev. 2024; 76(2):199-227.

PMID: 38351075 PMC: 10877757. DOI: 10.1124/pharmrev.122.000788.


Methylation pattern and mRNA expression of synapse-relevant genes in the MAM model of schizophrenia in the time-course of adolescence.

Khan A, Thielen L, Le Pen G, Krebs M, Kebir O, Groh A Schizophrenia (Heidelb). 2022; 8(1):110.

PMID: 36481661 PMC: 9732294. DOI: 10.1038/s41537-022-00319-8.


References
1.
Kumamoto N, Matsuzaki S, Inoue K, Hattori T, Shimizu S, Hashimoto R . Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindin. Biochem Biophys Res Commun. 2006; 345(2):904-9. DOI: 10.1016/j.bbrc.2006.04.163. View

2.
Veltman D, Insall R . WASP family proteins: their evolution and its physiological implications. Mol Biol Cell. 2010; 21(16):2880-93. PMC: 2921111. DOI: 10.1091/mbc.E10-04-0372. View

3.
Shi J, Levinson D, Duan J, Sanders A, Zheng Y, Peer I . Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature. 2009; 460(7256):753-7. PMC: 2775422. DOI: 10.1038/nature08192. View

4.
Tang J, LeGros R, Louneva N, Yeh L, Cohen J, Hahn C . Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression. Hum Mol Genet. 2009; 18(20):3851-63. PMC: 2748893. DOI: 10.1093/hmg/ddp329. View

5.
Chen X, Lee G, Maher B, Fanous A, Chen J, Zhao Z . GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Mol Psychiatry. 2010; 16(11):1117-29. PMC: 3443634. DOI: 10.1038/mp.2010.96. View